What they were paid
Camp4 Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $36,172 | $0 | $72,421 | — | $108,593 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Camp4 Therapeutics Corp DEF 14A filed April 23, 2026, accession 0001736730-26-000026, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Camp4 Therapeutics pays directors a $40,000 cash retainer and $10,359 in Stock Options.
The rest of the Camp4 Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Amir Nashat, ScD | Independent Director | $11,915 |
| Andrew J. Schwab | Independent Director | $12,692 |
| Douglas Williams, PhD | Chair of the Board | $120,723 |
| Josh Mandel-Brehm | Director | $0 |
| Michael Higgins | Independent Director | $70,359 |
| Michael MacLean | Director | $0 |
| Richard Young, PhD | Independent Director | $156,915 |
| Steven Holtzman | Independent Director | $164,109 |
The full Camp4 Therapeutics compensation record
free company briefThis page is one director within Camp4 Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat